Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
about
Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case reportThe future of viral hepatitis testing: innovations in testing technologies and approaches.To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis.OMNIgene.SPUTUM suppresses contaminants while maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport.
P2860
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Optimising molecular diagnosti ...... losis in high-burden settings.
@en
Optimising molecular diagnosti ...... losis in high-burden settings.
@nl
type
label
Optimising molecular diagnosti ...... losis in high-burden settings.
@en
Optimising molecular diagnosti ...... losis in high-burden settings.
@nl
prefLabel
Optimising molecular diagnosti ...... losis in high-burden settings.
@en
Optimising molecular diagnosti ...... losis in high-burden settings.
@nl
P2093
P50
P356
P1476
Optimising molecular diagnosti ...... losis in high-burden settings.
@en
P2093
E C W Farmer
G R Davies
I Honeyborne
M Hoelscher
P304
P356
10.5588/IJTLD.15.0951
P577
2016-08-01T00:00:00Z